In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Orphan Australia

Division of Jazz Pharmaceuticals PLC

Latest From Orphan Australia

An Australian vote for pharma: domestic players

Australian firms continue to carve a place in their home market – some more successfully than others.

Gynecology & Urology Infectious Diseases

Sigma receives bids for businesses

Sigma Pharmaceuticals has reportedly received three offers for its consumer health business Herron Pharmaceuticals and another three for its Orphan Australia drugs division.

Australia Deals

Australian TGA gives orphan status to thrombocythaemia drug

The Australian Therapeutics Goods Administration (TGA) has granted orphan status to Orphan Australia's Thromboreductin (anagrelide hydrochloride), 0.5mg and 1mg capsules. Thromboreductin is indicated for the treatment of essential thrombocythaemia in patients with high or intermediate risk of thrombosis or bleeding. It was approved on April 23rd.

Cardiovascular Australia

TGA designates four new orphan drugs

Australia's Therapeutics Goods Administration (TGA) designated four new orphan drugs in the end of October.

Metabolic Disorders Gynecology & Urology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Jazz Pharmaceuticals PLC
  • Senior Management
  • Alastair Young, Managing Dir.
  • Contact Info
  • Orphan Australia
    Phone: (61) 56 298581
    1806 Tonimbuk Rd.